Skip to main content
Erschienen in: European Child & Adolescent Psychiatry 8/2006

01.12.2006 | BRIEF REPORT

Increased mRNA levels of the mitochondrial complex I 75-kDa subunit

A potential peripheral marker of early onset schizophrenia?

verfasst von: Claudia Mehler-Wex, MD, J. Catharina Duvigneau, Romana T. Hartl, Dorit Ben-Shachar, Andreas Warnke, Manfred Gerlach

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 8/2006

Einloggen, um Zugang zu erhalten

Abstract

Recently, the dopamine D3-receptor mRNA on blood lymphocytes and platelet mitochondrial complex I were suggested as biological markers of schizophrenia in adults. We investigated the mRNA level of the dopamine D3-receptor and complex I subunits in whole blood cells of early-onset schizophrenic patients compared to healthy controls using quantitative real-time PCR. We found an increased mRNA expression of the complex I 75-kDa subunit (referred to beta-actin in schizophrenic patients (0.57 ± 0.24 versus 0.23 ± 0.18 in controls, P < 0.01)), but were unable to analyse the dopamine D3-mRNA expression. This increase appears to be inherent to schizophrenia, because it was found in neuroleptic-naive patients and it was not affected by neuroleptic treatment. Our preliminary findings suggest the mitochondrial complex I as a potential peripheral marker of schizophrenia and its involvement in the pathophysiology of this illness.
Literatur
1.
Zurück zum Zitat Ben-Shachar D, Zuk R, Gazawi H, Reshef A, Sheinkman A, Klein E (1999) Increased mitochondrial complex I activity in platelets of schizophrenic patients. Int J Neuropsychopharmacol 2:245–253PubMedCrossRef Ben-Shachar D, Zuk R, Gazawi H, Reshef A, Sheinkman A, Klein E (1999) Increased mitochondrial complex I activity in platelets of schizophrenic patients. Int J Neuropsychopharmacol 2:245–253PubMedCrossRef
2.
Zurück zum Zitat Dror N, Klein E, Karry R, Sheinkman A, Kirsh Z, Mazor M, Tzukerman M, Ben-Shachar D (2002) State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia. Mol Psychiatry 7:995–1001PubMedCrossRef Dror N, Klein E, Karry R, Sheinkman A, Kirsh Z, Mazor M, Tzukerman M, Ben-Shachar D (2002) State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia. Mol Psychiatry 7:995–1001PubMedCrossRef
3.
Zurück zum Zitat Ilani T, Ben-Shachar D, Strous RD, Mazor M, Sheinkman A, Kotler M, Fuchs S (2001) A peripheral marker for schizophrenia: increased levels of D3 dopamine receptor mRNA in blood lymphocytes. Proc Natl Acad Sci 98:625–628PubMedCrossRef Ilani T, Ben-Shachar D, Strous RD, Mazor M, Sheinkman A, Kotler M, Fuchs S (2001) A peripheral marker for schizophrenia: increased levels of D3 dopamine receptor mRNA in blood lymphocytes. Proc Natl Acad Sci 98:625–628PubMedCrossRef
4.
Zurück zum Zitat Hatefi Y (1985) The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem 54:1015–1069PubMedCrossRef Hatefi Y (1985) The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem 54:1015–1069PubMedCrossRef
5.
Zurück zum Zitat Remschmidt H (2002) Early-onset schizophrenia as a progressive-deteriorating developmental disorder: evidence from child psychiatry. J Neural Transm 109:101–117PubMedCrossRef Remschmidt H (2002) Early-onset schizophrenia as a progressive-deteriorating developmental disorder: evidence from child psychiatry. J Neural Transm 109:101–117PubMedCrossRef
6.
Zurück zum Zitat Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799–812CrossRef Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799–812CrossRef
7.
Zurück zum Zitat Goodall AH (1991) Platelet activation during preparation and storage of concentrates: detection by flow cytometry. Blood Coagul Fibrinolysis 2:377–382PubMed Goodall AH (1991) Platelet activation during preparation and storage of concentrates: detection by flow cytometry. Blood Coagul Fibrinolysis 2:377–382PubMed
8.
Zurück zum Zitat Härtel C, Bein G, Müller-Steinhardt M, Klüter H (2001) Ex vivo induction of cytokine mRNA expression in human blood samples. J Immunol Methods 249:63–71PubMedCrossRef Härtel C, Bein G, Müller-Steinhardt M, Klüter H (2001) Ex vivo induction of cytokine mRNA expression in human blood samples. J Immunol Methods 249:63–71PubMedCrossRef
9.
Zurück zum Zitat Rinder HM, Snyder EL (1992) Activation of platelet concentrate during preparation and storage. Blood cells 18:445–456PubMed Rinder HM, Snyder EL (1992) Activation of platelet concentrate during preparation and storage. Blood cells 18:445–456PubMed
10.
Zurück zum Zitat Badura F, Trott GE, Mehler C, Scheuerpflug P, Hofmann E, Warmuth-Metz M (2001) A study of cranial computertomograms in very early and early onset schizophrenia. J Neural Transm 108:1335–1344PubMedCrossRef Badura F, Trott GE, Mehler C, Scheuerpflug P, Hofmann E, Warmuth-Metz M (2001) A study of cranial computertomograms in very early and early onset schizophrenia. J Neural Transm 108:1335–1344PubMedCrossRef
11.
Zurück zum Zitat Mehler C, Warnke A (2002) Structural brain abnormalities specific to childhood-onset schizophrenia identified by neuroimaging techniques. J Neural Transm 109:219–234PubMedCrossRef Mehler C, Warnke A (2002) Structural brain abnormalities specific to childhood-onset schizophrenia identified by neuroimaging techniques. J Neural Transm 109:219–234PubMedCrossRef
12.
Zurück zum Zitat Ben-Shachar D (2002) Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J Neurochem 83:1241–1251PubMedCrossRef Ben-Shachar D (2002) Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J Neurochem 83:1241–1251PubMedCrossRef
13.
Zurück zum Zitat Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JJ, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA, Hester S, Tkachev D, Mimmack ML, Yolken RH, Webster MJ, Torrey EF, Bahn S (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9:684–697PubMedCrossRef Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JJ, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA, Hester S, Tkachev D, Mimmack ML, Yolken RH, Webster MJ, Torrey EF, Bahn S (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9:684–697PubMedCrossRef
Metadaten
Titel
Increased mRNA levels of the mitochondrial complex I 75-kDa subunit
A potential peripheral marker of early onset schizophrenia?
verfasst von
Claudia Mehler-Wex, MD
J. Catharina Duvigneau
Romana T. Hartl
Dorit Ben-Shachar
Andreas Warnke
Manfred Gerlach
Publikationsdatum
01.12.2006
Erschienen in
European Child & Adolescent Psychiatry / Ausgabe 8/2006
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-006-0560-5

Weitere Artikel der Ausgabe 8/2006

European Child & Adolescent Psychiatry 8/2006 Zur Ausgabe

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.